News

Driven by accelerating diagnosis of ATTR cardiomyopathy, sustained reliance on cost-effective chemotherapy, and rapid uptake of disease-modifying therapies in North…

Hear from a current student in the Clinical & Translational Research Certificate Program as they reflect on their experience in the program and the impact it…

The Transthyretin Amyloidosis – Quality of Life Questionnaire (ATTR-QOL) can effectively capture the multidimensional effect of ATTR, according to a new study…

Amyloid plaques accumulate years before dementia, driven by release of the Aβ peptide from amyloid precursor protein (APP) in neurons. Now, new evidence points to…

ORLANDO, Fla. - Cardiac amyloidosis is a systemic disorder that affects the heart and can also affect other organs such as the kidneys and nervous system.…

AbstractBackground and Objectives: Hereditary transthyretin amyloidosis (ATTRv) is a rare disease caused by pathogenic variants in the transthyretin (TTR) gene.…

Insulin-derived amyloidosis is a rare form of localised amyloidosis resulting from the aggregation of exogenous insulin into subcutaneous amyloid fibrils at…

AbstractAntibodies directed at the amyloid-β peptide offer the prospect of disease-modifying therapy for early-stage Alzheimer disease but also carry the risk of…

We are raising funds in loving memory of our mum, who sadly passed away from cardiac amyloidosis on 10/12/2025.Amyloidosis is a rare and often misunderstood…

Amyloidosis is a rare, chronic condition in which abnormal proteins bunch together to form amyloid deposits. These deposits can build in certain body organs such as…